SB 170 Nevada Senate · 2019 Regular Session

Revises provisions relating to health care. (BDR 54-523)

Summary
AN ACT relating to health care; revising requirements governing the injection of neuromodulators derived from Clostridium botulinum or dermal and soft tissue fillers; revising the definition of “chemical restraint” as used in provisions regulating the use of such restraint; and providing other matters properly relating thereto.
Bill status passed 3 of 5 stages cleared
Introduction
Feb 2019
Committee Review
Apr 2019
Senate Passage
Apr 2019
Assembly Passage
Governor
Introduced Feb 18, 2019 Last action May 18, 2019
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
7
Key actions
2
Committee
3
Apr 11, 2019
Committee
In Assembly. Read first time. Referred to Committee on Commerce and Labor. To committee.
lower
Apr 5, 2019
Upper · Passed
From committee: Amend, and do pass as amended.
upper
Feb 19, 2019
Upper · Passed
From printer. To committee.
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.